本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aerovate Therapeutics, Inc.

2.75
+0.07002.61%
盤後2.790.0400+1.45%19:40 EDT
成交量:17.77萬
成交額:48.46萬
市值:7,970.88萬
市盈率:-1.13
高:2.79
開:2.68
低:2.63
收:2.68
資料載入中...
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/29

重要事件披露

8-K - Current report
2022/03/30

重要事件披露

8-K - Current report
2022/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/19

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/07/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933